Hypertension is a major risk factor for heart attack, stroke, and kidney failure and contributes to over 350,000 deaths annually in the United States. Although hypertension is thought to be one of the most modifiable contributors to cardiovascular disease, our incomplete knowledge of the etiology of this complex disease trait has hindered our ability to therapeutically control blood pressure in a diverse population of affected patients. Recent studies in pre-clinical models indicate that the small GTPase protein, RhoA, regulates blood pressure by stimulating the contractility of smooth muscle cells (SMC) within resistance vessels. Although studies from our lab and others have shown that RhoA activity is regulated by cellular proteins that control its on/off state, the precise signaling mechanisms that control its activity in blood vessels are largely unknown. We have recently demonstrated that the Rho-specific GTPase activating protein, GRAF3, is highly and selectively expressed in SMC in mice and humans and inhibits RhoA-dependent contractility in this cell-type. Moreover, our data indicate that GRAF3's ability to limit RhoA activity in SMC is required for the maintenance of normal blood pressure and provide a novel mechanism for the blood pressure (BP) associated locus within the GRAF3 gene that was recently identified by Genome Wide Association Studies (GWAS). Interestingly, the BP- associated locus maps to the 80Kb first intron of the GRAF3 gene strongly suggesting that its effects on BP are mediated by alterations in GRAF3 expression. Indeed, the minor GRAF3 allele that decreases blood pressure is significantly associated with increased GRAF3 mRNA levels in human tibial artery samples. Taking advantage of our considerable expertise on the regulation of SMC-specific gene expression, we have already identified regulatory elements within the hypertensive locus that exhibit SMC-selective transcriptional activity and have shown that a minor allele variation within one of these elements significantly increased its transcriptional activity. The goal of this multi-PI, multidisciplinary proposal is to further examine the role of GRAF3 in the pathogenesis of human hypertension.
In aim 1 we will use our unique GRAF3-deficient mouse lines in combination with several well-characterized hypertensive models to determine the extent to which changes in vessel tone contribute to the development of hypertension and hypertension-induced cardiovascular disease. The goal of Aim2 is to identify the regulatory elements and transcription factors that drive SMC-specific GRAF3 expression and to identify the SNPs that alter the activities of GRAF3 regulatory elements. The goal of Aim3 is to test whether GRAF3 genotype correlates with GRAF3 levels and hypertension in patient populations. To this end, we have established collaborations with several clinical cardiovascular research teams at the University of North Carolina. We will continue to correlate genetic variations within the GARF3 gene with GRAF3 expression and a number of cardiovascular end-points including vascular stiffness and intermediate disease outcomes. The completion of these aims will add significantly to our understanding of the development and pathophysiologic consequences of hypertension and to novel and perhaps individualized approaches to the treatment of this prevalent and debilitating disease.

Public Health Relevance

Hypertension is a major risk factor for heart attack, stroke, and kidney failure and contributes to over 350,000 deaths annually in the United States. The goal of this proposal is to further characterize a novel mechanism for the control of blood pressure. The completion of our studies will add to our understanding of the development and consequences of hypertension and to novel and perhaps individualized approaches to the treatment of this prevalent and debilitating disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL130367-02
Application #
9197685
Study Section
Hypertension and Microcirculation Study Section (HM)
Program Officer
OH, Youngsuk
Project Start
2016-01-01
Project End
2019-12-31
Budget Start
2017-01-01
Budget End
2017-12-31
Support Year
2
Fiscal Year
2017
Total Cost
$735,395
Indirect Cost
$243,976
Name
University of North Carolina Chapel Hill
Department
Pathology
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Bressan, Michael; Henley, Trevor; Louie, Jonathan D et al. (2018) Dynamic Cellular Integration Drives Functional Assembly of the Heart's Pacemaker Complex. Cell Rep 23:2283-2291
Rozenberg, Julian M; Taylor, Joan M; Mack, Christopher P (2018) RBPJ binds to consensus and methylated cis elements within phased nucleosomes and controls gene expression in human aortic smooth muscle cells in cooperation with SRF. Nucleic Acids Res 46:8662
Bai, Xue; Mangum, Kevin D; Dee, Rachel A et al. (2017) Blood pressure-associated polymorphism controls ARHGAP42 expression via serum response factor DNA binding. J Clin Invest 127:670-680
Taylor, Joan M (2017) Editorial overview: Muscle and bone are highly effective communicators. Curr Opin Pharmacol 34:iv-vii
Bai, Xue; Mangum, Kevin; Kakoki, Masao et al. (2017) GRAF3 serves as a blood volume-sensitive rheostat to control smooth muscle contractility and blood pressure. Small GTPases :1-10
Giudice, Jimena; Taylor, Joan M (2017) Muscle as a paracrine and endocrine organ. Curr Opin Pharmacol 34:49-55
Cheng, Zhaokang; Zhu, Qiang; Dee, Rachel et al. (2017) Focal Adhesion Kinase-mediated Phosphorylation of Beclin1 Protein Suppresses Cardiomyocyte Autophagy and Initiates Hypertrophic Growth. J Biol Chem 292:2065-2079
Viera, Anthony J; Lin, Feng-Chang; Tuttle, Laura A et al. (2016) Examination of Several Physiological and Psychosocial Factors Potentially Associated With Masked Hypertension Among Low-Risk Adults. J Clin Hypertens (Greenwich) 18:784-9
Booth 3rd, John N; Muntner, Paul; Abdalla, Marwah et al. (2016) Differences in night-time and daytime ambulatory blood pressure when diurnal periods are defined by self-report, fixed-times, and actigraphy: Improving the Detection of Hypertension study. J Hypertens 34:235-43
Booth 3rd, John N; Muntner, Paul; Diaz, Keith M et al. (2016) Evaluation of Criteria to Detect Masked Hypertension. J Clin Hypertens (Greenwich) 18:1086-1094

Showing the most recent 10 out of 11 publications